(Total Views: 389)
Posted On: 03/07/2017 8:31:13 AM
Post# of 30066
Given that AMBS owns about 40% of Avant, does anyone have any updates on development/utilization of OvaDx, MSPrecise, LymPro, or Theralink? If just one of these diagnostics becomes a mainstream diagnostic tool covered by insurance it would be huge for AMBS.
(1)
(0)
